|
Real-time
Euronext Paris
04:54:53 2026-10-20 EDT
|
5-day change | 1st Jan Change | ||
| 26.88 EUR | +2.21% |
|
+1.13% | +6.67% |
| 10-14 | Medincell bolsters financial structure, Jefferies approves |  |
| 10-14 | French and Benelux stocks-Factors to watch | RE |
| Market Cap | 944M 1.06B 875M 795M 1.49B 100B 1.52B 10.49B 4.13B 52.5B 3.98B 3.89B 168B | P/E 2027 * |
-986x | P/E 2028 * | 63.9x |
|---|---|---|---|---|---|
| Enterprise Value | 926M 1.04B 858M 780M 1.46B 98.5B 1.49B 10.29B 4.05B 51.48B 3.9B 3.82B 165B | EV / Sales 2027 * |
23.8x | EV / Sales 2028 * | 16.1x |
| Free-Float |
66.06% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| MEDCL | Real-time | |
London S.E.
| 0ACH | Delayed | |
|
CBOE
| Real-time | ||
|
Börse Stuttgart
| MEB | Delayed | |
|
Tradegate
| MEB | Real-time | |
|
Deutsche Boerse AG
| MEB | Delayed | |
|
CBOE
| 0ACH | Real-time | |
|
Boerse Muenchen
| MEB | Real-time |
Last Transcript: MedinCell S.A.
| 1 day | +2.21% | ||
| 1 week | +1.13% | ||
| Current month | +11.54% | ||
| 1 month | +23.64% | ||
| 3 months | +7.09% | ||
| 6 months | +12.47% | ||
| Current year | +6.67% |
| 1 week | 25.04 |  | 27.1 |
| 1 month | 21.4 | | 32.38 |
| Current year | 19.69 | | 32.38 |
| 1 year | 19.69 | | 39.68 |
| 3 years | 5.25 | | 39.68 |
| 5 years | 4.73 | | 39.68 |
| 10 years | 4.35 | | 39.68 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Douat
CEO | Chief Executive Officer | 62 | 2003-01-08 |
Stéphane Postic
DFI | Director of Finance/CFO | 52 | 2023-08-31 |
Philippe Moyen
COO | Chief Operating Officer | - | 2024-09-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Douat
BRD | Director/Board Member | 62 | 2003-01-08 |
Philippe Guy
CHM | Chairman | - | 2024-03-12 |
Elisabeth Kogan
BRD | Director/Board Member | - | 2020-12-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 2/26/25 | Buy | General Counsel | 2,943 | 0.0099% | ||
| 2/21/25 | Buy | Chief Financial Officer | 3,749 | 0.0126% | ||
| 5/6/23 | Sell | Founder | 60,000 | 0.2376% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.21% | +1.13% | -23.51% | +340.66% | 1.06B | |
| -1.33% | +4.88% | +54.50% | +109.94% | 1,106B | |
| -0.69% | -3.77% | +31.35% | +66.62% | 612B | |
| -0.96% | +0.55% | +23.13% | +94.26% | 500B | |
| +1.34% | +7.20% | +37.21% | +61.38% | 367B | |
| -1.59% | -1.25% | +69.39% | +43.02% | 354B | |
| +0.48% | +4.61% | +19.84% | +47.17% | 286B | |
| +0.73% | +4.94% | -0.64% | +19.69% | 256B | |
| -1.75% | +1.76% | +42.21% | +51.44% | 230B | |
| -2.00% | +1.75% | +24.64% | +95.14% | 190B | |
| Average | -0.35% | +1.05% | +27.81% | +92.93% | 390.12B | |
| Weighted average by Cap. | -0.74% | +2.30% | +38.22% | +75.86% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 38.94M 43.69M 36.07M 32.8M 61.55M 4.14B 62.56M 433M 170M 2.16B 164M 160M 6.92B | 56.6M 63.5M 52.43M 47.67M 89.46M 6.02B 90.93M 629M 247M 3.15B 238M 233M 10.06B |
| Net income | -4.32M -4.84M -4M -3.64M -6.82M -459M -6.93M -47.96M -18.86M -240M -18.17M -17.79M -767M | 15.81M 17.74M 14.65M 13.32M 24.99M 1.68B 25.4M 176M 69.07M 879M 66.54M 65.15M 2.81B |
| Net Debt | -18.37M -20.6M -17.01M -15.47M -29.03M -1.95B -29.51M -204M -80.25M -1.02B -77.31M -75.69M -3.26B | -32.13M -36.05M -29.77M -27.06M -50.79M -3.42B -51.62M -357M -140M -1.79B -135M -132M -5.71B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-20 | €26.88 | +2.21% | 28,014 |
| 26-10-19 | €26.30 | +2.26% | 99,002 |
| 26-10-16 | €25.72 | -2.28% | 114,435 |
| 26-10-15 | €26.32 | -1.86% | 74,715 |
| 26-10-14 | €26.82 | +0.90% | 117,246 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MEDCL Stock
Select your edition
All financial news and data tailored to specific country editions
